Cancer Survivorship Clinics: The Next Need in Indian Oncology Care

Introduction

India's oncology story is changing shape. For decades, the conversation around cancer care in the country focused almost entirely on diagnosis, treatment access, and survival rates. That focus was necessary, and it has paid off. Early detection has improved, treatment protocols have become more sophisticated, and survival outcomes across several cancer types have strengthened considerably. But this progress has created a new and largely unaddressed challenge: a rapidly growing population of cancer survivors who need structured, long-term care once active treatment ends.

Global data now puts this shift in sharp focus. A recent WHO report projects that annual cancer cases worldwide will rise by more than sixty percent by 2050. In India, the National Cancer Registry Programme estimated over 14 lakh new cancer cases in 2022, and the country's survivor population is now estimated to have crossed three million. For oncologists, hospital administrators, and healthcare planners, the question is no longer only "how do we treat more patients?" It is increasingly "how do we care for the growing number of people who have already been treated."

This is precisely where cancer survivorship clinics enter the picture. They represent a distinct, structured model of care that sits between acute oncology treatment and general wellness, addressing the physical, psychological, financial, and social dimensions of life after cancer. For India's oncology ecosystem, building this layer of care is quickly becoming one of the most important priorities of the decade ahead.

Understanding Cancer Survivorship as a Distinct Phase of Care

Cancer survivorship is often misunderstood as simply the period after treatment ends. In clinical terms, it is far broader. It encompasses the entire experience of a person from the point of diagnosis through the rest of their life, including the management of ongoing side effects, the risk of recurrence or secondary cancers, and the practical realities of returning to work, family life, and community participation.

Survivors frequently continue to experience consequences of their treatment long after their last chemotherapy session or surgery. Fatigue, neuropathy, hormonal disturbances, cardiac strain from certain chemotherapy agents, lymphoedema, and cognitive changes are common and can persist for years. Alongside these physical effects, many survivors report anxiety about recurrence, depression, body image concerns, and difficulty resuming their previous professional or social roles. A recent WHO survey found that nearly half of cancer patients face financial hardship, while more than half report mental health challenges during and after treatment.

Framing survivorship as a distinct phase of care, rather than an informal afterthought once treatment concludes, is the first step toward building the systems India needs.

Why Survivorship Clinics Are Becoming Essential in India

Several converging factors make this an urgent priority rather than a distant aspiration.

The most obvious driver is scale. With India's survivor population already past three million and growing every year, the country cannot continue treating post-treatment care as an informal, unstructured add-on to oncology practice. A second driver is the changing nature of cancer itself in clinical thinking. Oncologists increasingly describe cancer as a long-term condition to be managed rather than a single episode to be cured, particularly for cancers with high survival rates such as certain breast, prostate, and paediatric cancers.

There is also a growing recognition, reflected in recent Indian medical literature, that rehabilitation and survivorship services remain concentrated in a handful of urban tertiary centres. Institutions such as the National Cancer Institute in Jhajjar, under AIIMS New Delhi, have begun offering structured rehabilitation services, but such models remain the exception rather than the norm. Most patients across India receive general physiotherapy through outpatient departments, often without multidisciplinary coordination or long-term follow-up planning.

For associations, hospital administrators, and healthcare leaders reading this, the opportunity is significant. Establishing even a modest survivorship framework, built around existing oncology infrastructure, can meaningfully change outcomes for thousands of patients without requiring an entirely new hospital or department.

Who Needs Survivorship Care and What It Should Address

Survivorship care is relevant across a wide range of cancer types and patient groups, though the specific needs vary considerably.

Adult survivors of breast, head and neck, colorectal, and haematological cancers frequently need monitoring for recurrence, management of treatment-related complications such as lymphoedema or neuropathy, and support returning to work. Paediatric and adolescent cancer survivors have a different set of long-term concerns, including growth and developmental monitoring, fertility counselling as they reach adulthood, and psychosocial support tied to schooling and social reintegration. A consensus statement developed by Indian paediatric oncologists following a national workshop recommended that survivors be risk-stratified into low, moderate, and high categories, with follow-up frequency adjusted accordingly, and that most survivors formally enter a survivorship programme around two years after treatment completion.

A well-designed survivorship clinic typically addresses several elements together: clinical surveillance for recurrence or secondary cancers, monitoring of growth and nutrition in younger patients, management of persistent treatment side effects, psychological and social support, and vocational or educational guidance where relevant. Importantly, experts recommend that survivorship clinics function as a distinct clinical space, separate from acute oncology visits, so that the tone and pace of the consultation can shift away from disease anxiety toward long-term wellbeing.

Building the Right Team and Care Pathway

A functioning survivorship clinic does not need to be elaborate from day one, but it does need a clear structure.

At a minimum, most clinical consensus points to three essential members: the treating oncologist, who ideally continues to lead survivorship planning given their familiarity with the patient's treatment history; an oncology nurse who manages coordination and follow-up; and a psychologist or counsellor who addresses the emotional dimensions of survivorship. Beyond this core team, access to physiotherapists, nutritionists, social workers, and relevant specialists such as cardiologists, endocrinologists, or fertility experts adds considerable depth, even if these specialists are not present at every single visit.

The care pathway itself matters as much as the team composition. Best practice suggests providing every patient with a detailed treatment summary at the end of active treatment, outlining the specific drugs, radiation fields, and cumulative doses received, since this information directly informs which late effects to monitor. Follow-up frequency should then be based on individual risk. Lower-risk survivors may transition to less frequent in-person visits over time, supplemented by virtual check-ins, while higher-risk survivors typically require closer surveillance for up to a decade or longer.

• Detailed end-of-treatment summary handed to every patient and family
• Risk-based follow-up schedule rather than a one-size-fits-all approach
• A named point of contact for coordination across specialists
• Clear transition planning as paediatric survivors move into adult care

The Role of Technology and Hybrid Care Models

Given India's geographic spread and the concentration of specialist oncology services in a small number of cities, technology has a meaningful role to play in extending survivorship care beyond hospital walls. Tele-consultations allow lower-risk survivors in Tier 2 and Tier 3 cities to maintain follow-up contact without repeated long-distance travel. Digital treatment summaries and reminder systems can help reduce the number of survivors who are lost to follow-up, a problem that Indian oncology literature has flagged as particularly common during the vulnerable transition period after treatment ends.

At the same time, technology should be treated as a support mechanism rather than a replacement for structured clinical judgement. In-person evaluation remains important at defined intervals, particularly for higher-risk survivors, and any digital system needs to be backed by a genuine multidisciplinary team rather than automated alerts alone. Platforms built around India's Ayushman Bharat Digital Mission framework are gradually creating the infrastructure needed to support this kind of longitudinal, connected record-keeping, which will be essential as survivorship programmes scale.

For doctors and associations exploring how digital tools fit into survivorship care, platforms like HealthVoice offer a space where clinicians can share experiences building such models, discuss what has worked at their institutions, and learn from peers navigating similar infrastructure and workforce constraints.

Policy Gaps and the Path Forward

Despite growing clinical recognition of its importance, survivorship care remains largely absent from formal national health policy in India. Rehabilitation and survivorship services are not yet mandated as a standard part of oncology care in the way that surgery, chemotherapy, or radiation are. This creates significant variation in what is available to patients depending on which hospital or city they are treated in.

There is meaningful potential to build survivorship components into existing public health infrastructure. Ayushman Bharat's Health and Wellness Centres, for instance, could serve as touchpoints for community-based follow-up and basic rehabilitation guidance, reducing the burden on tertiary centres for lower-risk survivors. Expanding insurance coverage to include rehabilitation and psychosocial support, rather than limiting coverage to acute hospitalisation, would also reduce the financial strain that many survivor families continue to experience well after treatment ends.

Workforce development is another pressing gap. India continues to face a shortage of specialists trained specifically in oncology rehabilitation and survivorship care, and medical curricula rarely include dedicated modules on this subject. Expanding postgraduate training seats, introducing fellowship programmes at major cancer centres, and building survivorship modules into MBBS and MD curricula would help build the specialist pipeline the country will need over the coming decade.

Conclusion

India's cancer story is entering a new chapter, one defined less by the number of new diagnoses and more by the growing number of people living years, and often decades, beyond their original treatment. That shift is worth recognising as a genuine achievement of modern oncology. But it also demands a corresponding shift in how care is structured. Survivorship clinics, built around risk-based follow-up, multidisciplinary teams, and realistic use of technology, offer India a practical way to meet this need without waiting for an entirely new system to be built from scratch. The institutions, associations, and individual doctors who begin building this layer of care now will be the ones shaping what long-term cancer care in India looks like for the next generation of survivors.

Frequently Asked Questions

Q1: What is a cancer survivorship clinic?

A cancer survivorship clinic is a dedicated care setting, separate from acute oncology treatment, that focuses on the long-term physical, psychological, and social needs of patients after their primary cancer treatment has ended.

Q2: Why does India need dedicated survivorship clinics now?

India's cancer survivor population has crossed three million and continues to grow, yet most oncology centres remain structured mainly for diagnosis and treatment, leaving long-term monitoring and rehabilitation largely unaddressed.

Q3: Who should be part of a survivorship care team?

At minimum, the team should include the treating oncologist, an oncology nurse, and a psychologist, ideally supported by physiotherapists, nutritionists, social workers, and specialists such as cardiologists or endocrinologists as needed.

Q4: Does Ayushman Bharat currently cover survivorship care?

Ayushman Bharat primarily covers hospitalisation and treatment costs at present. Long-term survivorship services such as rehabilitation and counselling are not yet comprehensively included, though there is growing advocacy for expansion in this direction.

Q5: How long should cancer survivors continue medical follow-up?

Many clinicians recommend lifelong follow-up, with the frequency of visits based on the individual survivor's risk of recurrence and the specific long-term effects associated with the treatment they received.

Resources

1. Indian Council of Medical Research (ICMR): National Cancer Registry Programme incidence data and publications
2. World Health Organization (WHO): Global cancer burden reports and patient survey findings
3. Pediatric Hematology Oncology Journal: Consensus statement on establishing childhood cancer survivorship clinics in India
4. World Journal of Clinical Oncology: Review on cancer rehabilitation status and scope in India
5. Ministry of Health and Family Welfare, Government of India: Ayushman Bharat and National Health Policy resources

Interlinking Keywords

cancer survivorship care, oncology rehabilitation in India, post-treatment cancer care, childhood cancer survivor clinics, cancer follow-up care, multidisciplinary oncology teams, Ayushman Bharat cancer coverage, doctor community platform

Last medically reviewed by:

Editorial Medical Review Panel, HealthVoice on July 13, 2026

Medical Disclaimer:

This article is intended for informational and professional awareness purposes only and does not constitute medical advice. Readers should consult qualified oncologists or healthcare providers for guidance specific to individual patient circumstances. HealthVoice does not endorse any specific product, treatment, or institution mentioned or implied in this content.

#CancerSurvivorship #OncologyCare